IHE icon

iShares US Pharmaceuticals ETF

125 hedge funds and large institutions have $143M invested in iShares US Pharmaceuticals ETF in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 11 closing their positions.

Holders
125
Holders Change
+3
Holders Change %
+2.46%
% of All Funds
2.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
34
Reduced
30
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Citigroup
101
Citigroup
New York
$19K 100
DSC
102
Duncker Streett & Co
Missouri
$19K 100
HI
103
Harbour Investments
Wisconsin
$19K 100 +100 New
US Bancorp
104
US Bancorp
Minnesota
$18K 94
National Bank of Canada
105
National Bank of Canada
Quebec, Canada
$14K 74
GRP
106
Global Retirement Partners
California
$14K 74
OHWP
107
Oak Harbor Wealth Partners
North Carolina
$13K 70
Bessemer Group
108
Bessemer Group
New Jersey
$11K 55
S
109
SignatureFD
Georgia
$10K 50
Fifth Third Bancorp
110
Fifth Third Bancorp
Ohio
$10K 50
AA
111
AlphaMark Advisors
Kentucky
$10K 50
Carson Wealth (CWM LLC)
112
Carson Wealth (CWM LLC)
Nebraska
$10K 50 +50 New
APA
113
American Portfolios Advisors
New York
$9.58K 50
OLVIG
114
Oliver Lagore Vanvalin Investment Group
Michigan
$8K 42
AA
115
Ancora Advisors
Ohio
$7K 37 +37 New
BC
116
Bartlett & Co
Ohio
$6K 30
BCWM
117
Bartlett & Co Wealth Management
Ohio
$5.75K 30
SWA
118
SOA Wealth Advisors
New York
$5K 28
NFSG
119
Newbridge Financial Services Group
Florida
$3K 15 +15 New
CWC
120
Carolinas Wealth Consulting
North Carolina
$2K 8
NSIM
121
North Star Investment Management
Illinois
$1K 7
CAAS
122
Capital Asset Advisory Services
Michigan
$1K 3
RG
123
Retirement Group
California
$1K 4
TFA
124
Transamerica Financial Advisors
Florida
$1K 1 +1 New
Bank of Montreal
125
Bank of Montreal
Ontario, Canada
$398 2,031 +478 +31%